Clinical Trials

Search for actively enrolling clinical trials

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment

Study ID: STU-2021-0108

Summary

nada!

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
PERRIN C WHITE

Contact:

Michelle Murphy

Michelle.Murphy@UTSouthwestern.edu

Linked In Email
scroll to top